WELLS FARGO & COMPANY/MN - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 45 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,788
+6.0%
1,0000.0%0.00%
Q2 2023$1,687
-56.6%
1,000
-50.0%
0.00%
Q1 2023$3,888
+107.9%
2,000
+100.0%
0.00%
Q4 2022$1,870
-6.5%
1,0000.0%0.00%
Q3 2022$2,000
-100.0%
1,000
-100.0%
0.00%
-100.0%
Q2 2022$6,903,000
-3.8%
5,462,0000.0%0.00%0.0%
Q1 2022$7,174,000
+23.4%
5,462,000
+37.0%
0.00%
+100.0%
Q4 2021$5,815,000
-55.0%
3,988,000
-54.7%
0.00%
-66.7%
Q3 2021$12,929,000
-1.2%
8,798,000
-10.2%
0.00%0.0%
Q2 2021$13,092,000
+2.3%
9,798,000
+0.0%
0.00%0.0%
Q1 2021$12,795,000
+2560.1%
9,795,000
+4897.4%
0.00%
Q4 2020$481,000
-66.7%
196,000
-71.8%
0.00%
Q3 2020$1,443,000
-9.8%
696,0000.0%0.00%
Q2 2020$1,599,000
-57.3%
696,000
-71.1%
0.00%
-100.0%
Q1 2020$3,745,000
-60.7%
2,405,000
-66.7%
0.00%
-66.7%
Q3 2019$9,539,000
-19.9%
7,221,000
+34.0%
0.00%0.0%
Q2 2019$11,902,000
-20.7%
5,388,000
-35.3%
0.00%
-25.0%
Q1 2019$15,015,0008,325,0000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 53,865,000$101,127,2803.93%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$165,397,6133.42%
Boussard & Gavaudan Investment Management LLP 11,898$21,871,5382.42%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$71,834,2261.71%
WOLVERINE ASSET MANAGEMENT LLC 79,876,000$149,367,3841.55%
CSS LLC/IL 4,747,000$8,868,6060.50%
Opti Capital Management, LP 3,000,000$5,611,9380.48%
Verition Fund Management LLC 16,459,000$30,786,5600.48%
Aequim Alternative Investments LP 5,000,000$9,352,5000.25%
MIZUHO SECURITIES USA LLC 1,097,000$2,047,6160.19%
View complete list of SAREPTA THERAPEUTICS INC shareholders